Yvonne L. Greenstreet
2018
In 2018, Yvonne L. Greenstreet earned a total compensation of $2.7M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 172% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,000 |
|---|---|
| Option Awards | $1,801,063 |
| Salary | $540,000 |
| Other | $125,692 |
| Total | $2,682,755 |
Greenstreet received $1.8M in option awards, accounting for 67% of the total pay in 2018.
Greenstreet also received $216K in non-equity incentive plan, $540K in salary and $125.7K in other compensation.
Rankings
In 2018, Yvonne L. Greenstreet's compensation ranked 4,355th out of 14,244 executives tracked by ExecPay. In other words, Greenstreet earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,355 out of 14,244 | 69th |
Division Manufacturing | 1,617 out of 5,759 | 72nd |
Major group Chemicals And Allied Products | 580 out of 2,122 | 73rd |
Industry group Drugs | 484 out of 1,811 | 73rd |
Industry Pharmaceutical Preparations | 376 out of 1,385 | 73rd |
Source: SEC filing on April 2, 2021.
Greenstreet's colleagues
We found four more compensation records of executives who worked with Yvonne L. Greenstreet at Alnylam Pharmaceuticals in 2018.